Skip to main content
ImmuneCited

Multiple sclerosis.

Alan Gaby
Review Global advances in health and medicine 2013 19 citazioni
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D24381825'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo di studio
Review
Popolazione
Patients with multiple sclerosis
Intervento
Multiple sclerosis. None
Comparatore
None
Esito primario
Multiple sclerosis management overview
Direzione dell'effetto
Neutral
Rischio di bias
Unclear

Abstract

Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system. Common manifestations include paresthesias, diplopia, loss of vision, numbness or weakness of the limbs, bowel or bladder dysfunction, spasticity, ataxia, fatigue, and mental changes. Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapsing. The cause of MS is unknown, although it appears to be an autoimmune disease. Much of what is known about MS has been learned from an animal model of the disease, experimental allergic encephalomyelitis.

TL;DR

Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapse, which is an autoimmune disease.

Used In Evidence Reviews

Similar Papers